Great Point Partners (GPP) has announced a growth investment in Ephicacy Consulting Group.
Ephicacy, based in Iselin, N.J., is a biometrics contract research organization. Founded in 2005, the company provides outsourced statistical programming, data management and “real-world” evidence analytics services to pharmaceutical and biotechnology companies.
GPP, based in Greenwich, Conn., is a private investment firm focused on the healthcare industry. Founded in 2003, the firm targets investments in biopharmaceutical supply chain services and products; healthcare services; healthcare information technology-enabled services; and medical devices and diagnostics in businesses operating in the United States, Canada and Western Europe. GPP pursues companies generating between $10 million and $100 million of revenue and $2 million to $12 million of EBITDA, with equity investments ranging from $7 million to $50 million.
Terms of the investment were not disclosed.